|
ZNF696 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.712400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.638830E-01 |
| Normal-vs-Stage2 |
9.134800E-01 |
| Normal-vs-Stage3 |
6.895000E-01 |
| Normal-vs-Stage4 |
8.720200E-01 |
| Stage1-vs-Stage2 |
3.652800E-01 |
| Stage1-vs-Stage3 |
5.838400E-02 |
| Stage1-vs-Stage4 |
2.714400E-01 |
| Stage2-vs-Stage3 |
6.726200E-01 |
| Stage2-vs-Stage4 |
9.903000E-01 |
| Stage3-vs-Stage4 |
5.858400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.577000E-01 |
| Normal-vs-AfricanAmerican |
1.233860E-02 |
| Normal-vs-Asian |
4.703600E-02 |
| Caucasian-vs-AfricanAmerican |
1.257190E-03 |
| Caucasian-vs-Asian |
8.134200E-02 |
| AfricanAmerican-vs-Asian |
7.299400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.449000E-01 |
| Normal-vs-Female |
9.642500E-02 |
| Male-vs-Female |
3.715700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.155200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.295600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.709600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.822200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.928200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.294600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.878600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.147600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.196800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.510800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.87200000001386E-06 |
| Normal-vs-Grade 2 |
6.529800E-02 |
| Normal-vs-Grade 3 |
7.206600E-01 |
| Normal-vs-Grade 4 |
1.390220E-01 |
| Grade 1-vs-Grade 2 |
1.361780E-03 |
| Grade 1-vs-Grade 3 |
1.88624999999387E-05 |
| Grade 1-vs-Grade 4 |
8.18159999749213E-08 |
| Grade 2-vs-Grade 3 |
8.219000E-03 |
| Grade 2-vs-Grade 4 |
4.822400E-04 |
| Grade 3-vs-Grade 4 |
2.163400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.481420E-01 |
| Normal-vs-ccB subtype |
1.931790E-01 |
| ccA subtype-vs-ccB subtype |
8.790700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.783000E-01 |
| Normal-vs-N1 |
3.569000E-01 |
| N0-vs-N1 |
5.801800E-01 |
|
|
